• Featured Product
  • KD/KO Validated

CCDC50 Polyclonal antibody

CCDC50 Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IF, IHC, ELISA

Conjugate

Unconjugated

Cat no : 21082-1-AP

Synonyms

C3orf6, CCDC50, DFNA44, Protein Ymer, YMER



Tested Applications

Positive WB detected inK-562 cells, L02 cells, mouse lung tissue, mouse skeletal muscle tissue, rat skeletal muscle tissue
Positive IHC detected inhuman kidney tissue, human brain tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:6000
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

21082-1-AP targets CCDC50 in WB, IF, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen CCDC50 fusion protein Ag15293
Full Name coiled-coil domain containing 50
Calculated Molecular Weight 482 aa, 56 kDa
Observed Molecular Weight 36-38 kDa
GenBank Accession NumberBC065004
Gene Symbol CCDC50
Gene ID (NCBI) 152137
RRIDAB_10695770
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

CCDC50 encodes Ymer, an effector of epidermal growth factor (EGF)-mediated cell signaling that is ubiquitously expressed in different organs and has been suggested to inhibit down-regulation of the EGF receptor. CCDC50 act as a multifunctional regulator in NF-κB and Fas signaling pathways. In chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL), CCDC50 is required for the survival of MCL and CLL cancer cells. Recently, CCDC50 was shown to promote hepatocellular carcinoma through the Ras/Foxo4 signaling pathway. (PMID: 34453126, PMID: 32612200, PMID: 17503326)

Protocols

Product Specific Protocols
WB protocol for CCDC50 antibody 21082-1-APDownload protocol
IHC protocol for CCDC50 antibody 21082-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
human,mouseWB,IHC,IF

EMBO Rep

CCDC50 promotes tumor growth through regulation of lysosome homeostasis

Authors - Penghui Jia
  • KD Validated